The Center for Biosimilars Interview: Axinn’s Landmon Provides an Expert Legal Opinion on HHS’ Drug Price Strategy
September 22, 2021
The Center for Biosimilars
Axinn partner Chad Landmon participated in a video interview with The Center for Biosimilars, where he discussed HHS’ Drug Price Strategy.
Click here to access the interview.